OlgahospitalStuttgart, Baden-Wurttemberg, Germany
Paper 01 - LAROTRECTINIB (LARO) SAFETY AND EFFICACY IN PATIENTS (PTS) WITH TRK FUSION SARCOMAS AND PROLONGED RESPONSE
Thursday, November 13, 202510:30 AM - 11:30 AM EST
Disclosure information not submitted.